The House of Representatives has passed a short-term funding bill aimed at giving the hemp industry additional time to contest an impending ban on its products. The bill, which funds the government through December 11, saw a 370-48 vote, with 19 Republicans and 29 Democrats opposing it. Previously, the Senate had passed this measure, and it now awaits approval from President Trump.
Delay on Hemp-Derived THC Products Ban
This legislation delays the federal prohibition on various hemp-derived THC items, such as gummies and beverages, by one month. Industry groups are celebrating this as an opportunity to persuade lawmakers to regulate rather than ban their products. The U.S. Hemp Roundtable expressed its commitment to use this extension to work with lawmakers and stakeholders on a federal framework that ensures consumer safety and protects businesses.
“This extension gives us one additional month, and we intend to make every day count,” the U.S. Hemp Roundtable stated.
The delay, however, excludes products with cannabinoids that cannot occur naturally in the Cannabis sativa L. plant, which will still be banned starting November 12. This affects products, often of illicit origin, which might come from countries like China. However, naturally producible cannabinoids like delta-8 THC, delta-10 THC, and THCP remain available in retail outlets until at least December 11.
Debate on Protection and Regulation
Proponents of the initial ban emphasize their intent to safeguard children from products containing high levels of synthetic THC often marketed to minors. These products, although labeled as hemp, include the psychoactive compound THC found in marijuana.
The delay has become a priority for the White House, suggesting a significant legislative push is likely to occur this winter. Despite recent efforts, the administration indicated it would not seek further delays beyond this.
Additional Healthcare News
This week, Panorama Produce recalled mangoes distributed in New York, New Jersey, Connecticut, and Pennsylvania due to potential salmonella contamination, as announced by the FDA.
In related news, President Trump appointed Darrell Scott as the tobacco health adviser for the CDC.
Reproductive Freedom for All, alongside Senate Majority PAC, launched a $250,000 campaign targeting Senator Susan Collins regarding her 2018 vote to confirm Supreme Court Justice Brett Kavanaugh, pivotal in overturning Roe v. Wade.
The CDC has also contested two measles deaths counted by Pennsylvania, omitting them from its weekly reports.
Health Headlines Across the Nation
- Texas is dealing with a Medicaid application backlog exceeding 210,000.
- North Carolina utilized federal funds to integrate mental health services across six school districts.
- Michigan faces a healthcare worker shortage impacting almost every sector.
Thank you for staying informed with us. For more updates, sign up for our Health Care newsletter.
Leave a Reply